Reduced multidrug resistance-associated protein 2 in ticlopidine-induced cholestatic liver injury

This publication has 9 references indexed in Scilit:

• Drug-Induced Liver Injury — Types and Phenotypes
  New England Journal of Medicine, 2019
• Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications
  Journal of Hepatology, 2018
• Dysregulation of BSEP and MRP2 May Play an Important Role in Isoniazid-Induced Liver Injury via the SIRT1/FXR Pathway in Rats and HepG2 Cells
  Biological and Pharmaceutical Bulletin, 2018
• The role of Ntcp, Oatp2, Bsep and Mrp2 in liver injury induced by Dioscorea bulbifera L. and Diosbulbin B in mice
  Environmental Toxicology and Pharmacology, 2017
• Nuclear Receptors and the Regulation of Drug‐Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs
  The Journal of Clinical Pharmacology, 2007
• Evaluation of 170 Xenobiotics as Transactivators of Human Pregnane X Receptor (hPXR) and Correlation to Known CYP3A4 Drug Interactions
  Current Drug Metabolism, 2006
• Chemiluminescence Quantitative Immunohistochemical Determination of MRP2 in Liver Biopsies
  Journal of Histochemistry & Cytochemistry, 2005
• Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge
  Journal of Clinical Epidemiology, 1993
• THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE
  The Lancet, 1989